The California Institute for Telecommunications and Information Technology (Calit2) at the University of California, San Diego has become the inaugural test site for a new approach to cooling computer servers – a technology that could improve energy efficiency and enable higher-performance computing.
UC San Diego’s Center for Transplantation has met or exceeded all of its necessary requirements for approval as a center of excellence under the Federal Medicare program. This approval – from the Center for Medicare and Medicaid Services (CMS) – allows UC San Diego Health System to accept into its program potential cardiac transplant patients covered by Medicare.
Adah Almutairi, associate professor at the Skaggs School of Pharmacy and Pharmaceutical Sciences, the department of nanoengineering, and the materials science and engineering program at the UC San Diego, and colleagues have developed the first degradable polymer that is extremely sensitive to low but biologically relevant concentrations of hydrogen peroxide.
UC San Diego Moores Cancer Center launched a bold plan today, aimed at personalizing cancer treatment. The “My Answer to Cancer” team of oncologists, bioinformaticians, pathologists and geneticists pledges to “sequence” or analyze the DNA of large numbers of patients with cancer in order to match each patient to the best available drug for his or her particular tumor.
Chemists at UC San Diego have developed a method that for the first time provides scientists the ability to attach chemical probes onto proteins and subsequently remove them in a repeatable cycle.
The San Diego Supercomputer Center is seeking innovative applications for the next round of user allocations on its data-intensive Gordon supercomputer, which went into operation earlier this year.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
